Motixafortide (BL-8040)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Motixafortide (BL-8040), covering 2025-12-16 to 2025-12-16. Get the full timeline:
Most recent: Clinical Trial Update: Mobilization of Stem Cells With Motixafortide (BL-8040) in Combination With G-CSF in Multiple Myeloma Patients [Phase 3]